Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus Clinical research trials and Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus. Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus clinical trial. Participants oftentimes recieve the finest healthcare available for their Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "E" Clinical Trials Conditions > Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus

Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus



Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus

For Condition: Systemic Lupus Erythematosus
Status: Completed
Sponsor(s): National Center for Research Resources (NCRR) , National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),Northwestern University
Synopsis: OBJECTIVES: I. Evaluate whether pregnancy is an independent risk factor that affects disease activity in women with systemic lupus erythematosus. II. Evaluate whether maternal disease activity is a risk factor for adverse pregnancy outcome.
Details: PROTOCOL OUTLINE: This is a case-controlled study. Intensive data collection begins when a patient becomes pregnant. Pregnant women are evaluated with interval pregnancy/exposure history and a clinical exam, including the Systemic Lupus Activity Measure (SLAM). Assessments are scheduled every 3 months as follows: visit 1 when the pregnancy is confirmed, visit 2 during the second trimester, visit 3 during the third trimester, visit 4 at 3 months postpartum, and visit 5 at 6 months postpartum. Visits 4 and 5 include an infant exam for growth and morphologic parameters; these visits occur on the same schedule if there is a miscarriage or stillbirth. Patients not currently pregnant are randomly chosen to be followed as controls. These patients undergo a review of current pregnancy status and measures of disease activity, including SLAM, every 3 months for 5 visits.
Eligibility:
Study Type:
  Observational, Screening, Longitudinal
Minimum Age/Maximum Age: 18 Years/50 Years
Genders: Female
Protocol Entry Criteria: - Definite or probable systemic lupus erythematosus meeting American College of Rheumatology criteria
Total Enrollment: 480

Location and Contact Information:

Overall Study Official:
RosalindRamsey-Goldman,  Study Chair,  Northwestern University


Additional Information:
Study ID Numbers:
  199/11926;  NU-501
Study Start Date: February 1994
Record last reviewed: February 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004663

Other Systemic Lupus Erythematosus Studies:
1. Prevention of Atherosclerosis and Heart Disease in Patients with Systemic Lupus Erythematosis (SLE)

2. Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus

3. Prevention of Arthritis-Related Work Disability

4. Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus

5. Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders

Related Studies:

Other Systemic Lupus Erythematosus Clinical Trials
Other Clinical Trials
Other Clinical Trials

Epidemiologic Study of Reproductive Outcome in Women with Systemic Lupus Erythematosus

Modify your Search

  Other Systemic Lupus Erythematosus Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103